NCT02244229

Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients

MICTUS (Multicentre Investigation to Characterise the Effect of Tamsulosin on Urinary Symptoms): A Multicentre, Double-blind, Randomised, Parallel Group Study, Aimed at Characterising the Effect of Tamsulosin, an Uroselective α1- Receptor Blocking Agent, on the Urological Symptoms and Their Impact on General Health Status and Quality of Life in Outpatients Affected by Symptomatic Benign Prostatic Hyperplasia: Comparison With Finasteride.

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 403 (actual)
• Sponsor: Boehringer Ingelheim · Industry
• Sex: Male
• Age: 50 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Study to evaluate the therapeutic effect of tamsulosin and finasteride in symptomatic BPH patients, two medications indicated in BPH belonging to two different pharmacological classes, as evaluated from the point of view of patient's perception of his pathological condition and of the impact of the disease on general health and quality of life

Conditions

• Prostatic Hyperplasia

Interventions

Type	Name	Description
DRUG	Tamsulosin
DRUG	Finasteride
DRUG	Placebo

Timeline

• Start date: 1998-04-01
• Primary completion: 2000-11-01
• First posted: 2014-09-19
• Last updated: 2014-09-19